Reference intervals of serum lipids in the second and third trimesters of pregnancy in a Caucasian cohort: the LIFE Child study.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
12 2019
Historique:
received: 06 05 2019
accepted: 15 10 2019
pubmed: 2 11 2019
medline: 23 6 2020
entrez: 1 11 2019
Statut: ppublish

Résumé

The study aimed to establish reference intervals for serum lipids and apolipoproteins in pregnant women depending on trimester and parity, and to investigate the influence of various factors on lipid and apolipoprotein concentrations. A total of 748 pregnant women (n = 683 in the second trimester, n = 676 in the third trimester) were included in the study and reference intervals for total cholesterol (TC), HDL, LDL, triglycerides (TG), apoA1 and apoB were determined as empirical quantiles. The measurement of serum lipids was performed using a validated specific homozygous enzymatic color test. Hierarchical models were used to investigate hypothesized relations. Except for apoA1, all serum lipids levels showed a significant change from the second to the third trimester. This increase was most pronounced for TGs. Especially in the third trimester, the concentrations of serum lipids exceeded the currently accepted reference values for non-pregnant women by a factor of 2.5. Reference intervals of serum lipids at the second and third trimesters in healthy pregnant women were as following: TC 4.45-8.99 and 4.83-9.71 mmol/l, HDL 1.33-3.06 and 1.16-3.13 mmol/l, LDL 2.14-6.11 and 2.35-6.98 mmol/l, TG 0.92-3.0 and 1.37-4.76 mmol/l as well as apoB 0.69-1.93 and 0.85-2.21 g/l. Parity and nutrient intake were not significantly associated with changes in lipid concentration. Prematurity was associated with a significant decrease in TC and TG levels. Detailed reference values for serum lipids and apolipoproteins in pregnancy are now available for a Caucasian cohort. Further, long-term studies are still needed to assess the effect of the extensive concentration changes of serum lipids in pregnancy and their atherogenic risk definitively.

Sections du résumé

BACKGROUND
The study aimed to establish reference intervals for serum lipids and apolipoproteins in pregnant women depending on trimester and parity, and to investigate the influence of various factors on lipid and apolipoprotein concentrations.
MATERIALS AND METHODS
A total of 748 pregnant women (n = 683 in the second trimester, n = 676 in the third trimester) were included in the study and reference intervals for total cholesterol (TC), HDL, LDL, triglycerides (TG), apoA1 and apoB were determined as empirical quantiles. The measurement of serum lipids was performed using a validated specific homozygous enzymatic color test. Hierarchical models were used to investigate hypothesized relations.
RESULTS
Except for apoA1, all serum lipids levels showed a significant change from the second to the third trimester. This increase was most pronounced for TGs. Especially in the third trimester, the concentrations of serum lipids exceeded the currently accepted reference values for non-pregnant women by a factor of 2.5. Reference intervals of serum lipids at the second and third trimesters in healthy pregnant women were as following: TC 4.45-8.99 and 4.83-9.71 mmol/l, HDL 1.33-3.06 and 1.16-3.13 mmol/l, LDL 2.14-6.11 and 2.35-6.98 mmol/l, TG 0.92-3.0 and 1.37-4.76 mmol/l as well as apoB 0.69-1.93 and 0.85-2.21 g/l. Parity and nutrient intake were not significantly associated with changes in lipid concentration. Prematurity was associated with a significant decrease in TC and TG levels.
CONCLUSION
Detailed reference values for serum lipids and apolipoproteins in pregnancy are now available for a Caucasian cohort. Further, long-term studies are still needed to assess the effect of the extensive concentration changes of serum lipids in pregnancy and their atherogenic risk definitively.

Identifiants

pubmed: 31667609
doi: 10.1007/s00404-019-05342-2
pii: 10.1007/s00404-019-05342-2
doi:

Substances chimiques

APOA1 protein, human 0
APOB protein, human 0
Apolipoprotein A-I 0
Apolipoprotein B-100 0
Apolipoproteins 0
Lipids 0
Triglycerides 0
Cholesterol 97C5T2UQ7J

Banques de données

ClinicalTrials.gov
['NCT02550236']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1531-1539

Auteurs

Anne Dathan-Stumpf (A)

LIFE Child- Leipzig Research Center for Civilization Diseases, Leipzig University, 04103, Leipzig, Germany. anne.dathan-stumpf@medizin.uni-leipzig.de.
Department of Obstetrics, University Hospital Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany. anne.dathan-stumpf@medizin.uni-leipzig.de.

Mandy Vogel (M)

LIFE Child- Leipzig Research Center for Civilization Diseases, Leipzig University, 04103, Leipzig, Germany.
Centre of Paediatric Research (CPL), Leipzig University, 04103, Leipzig, Germany.

Alexander Jank (A)

Department of Obstetrics, University Hospital Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany.

Joachim Thiery (J)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital, 04103, Leipzig, Germany.

Wieland Kiess (W)

LIFE Child- Leipzig Research Center for Civilization Diseases, Leipzig University, 04103, Leipzig, Germany.
Hospital for Children and Adolescents, University Hospital, 04103, Leipzig, Germany.
Centre of Paediatric Research (CPL), Leipzig University, 04103, Leipzig, Germany.

Holger Stepan (H)

Department of Obstetrics, University Hospital Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH